Tomoyuki Satake

8PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 08, 2026
Autologous Glypican-3-Targeted, Armored CAR T Cells in Patients with Advanced Solid Tumors: A Phase 1 Dose-Escalation Study of TAK-102.

|Jul 17, 2025
Epidemiologic Features and Age-Related Differences in Management among Patients with Gastrointestinal Stromal Tumors in Japan: A National Cancer Registry Study.

Hidekazu Hirano, Yoichi Naito, Toshirou Nishida

|May 03, 2025
Multicenter observational study to characterize fibroblast growth factor receptor 2 fusions or rearrangements in patients with advanced/metastatic cholangiocarcinoma.

Tomoyuki Satake, Chigusa Morizane, Hiroyuki Isayama

|Dec 09, 2024
Prevalence of HER3 Expression in Pancreatic Cancer Patients Treated With Systemic Chemotherapy.

Tomoyuki Satake, Chigusa Morizane, Mao Okada

|Nov 02, 2023
Pathogenic Germline Variants in BRCA1/2 and p53 Identified by Real-world Comprehensive Cancer Genome Profiling Tests in Asian Patients.

Tomoyuki Satake, Shunsuke Kondo, Noriko Tanabe

|Sep 26, 2022
The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry.

Tomoyuki Satake, Chigusa Morizane, Ryoko Rikitake

Pageof 2

Frequent Collaborators

2 joint publications

Shunsuke Kondo

2 joint publications

Yuki Katsuya

2 joint publications

Takafumi Koyama

1 joint publications

Noriko Tanabe